Bayer is reviewing the results of the Canadian study of their Trasylol heart medication drug. Trasylol problems including kidney failure, stroke and death have affected thousands of patients across the United States. The Canadian study (referred to as the “BART” study) was a randomized clinical trial involving patients who underwent one of the following procedures: repeat cardiac surgery, isolated mitral-valve replacement, combined valve and CABG surgery, multiple valve replacement or repair, and surgery of the ascending aorta or aortic arch procedures.
The BART study was stopped after a planned periodic data analysis indicated reduced bleeding but also an increase in all-cause mortality for patients in the aprotinin (Trasylol) treatment arm compared to patients who received either of the generic drugs aminocaproic acid or tranexamic acid. Bayer is waiting until more information becomes available following their final data analysis before they take further action regarding Trasylol.
If you or a loved one has had open heart surgery and then experienced Trasylol kidney failure, heart failure or stroke, you may be able entitled to money damages. A Trasylol lawsuit attorney can help evaluate your claim.
We are a Law Firm that is dedicated to helping people who have been affected by Trasylol side effects.
Personal Injury Law Firm
Patients and families nationwide have looked at filing a Trasylol lawsuit based on the often fatal side effects of the drug Trasylol. Currently no Trasylol class action suits have been filed by Fields Law Firm and claims are being made individually.
The lawsuits claim that Bayer, the drug’s manufacturer, was negligent in several ways including:
• marketing [...]
The Trasylol heart surgery drug has increasingly been linked to serious side effects including kidney failure and stroke following bypass surgery. Many patients and families have questioned whether Bayer’s heart medication, also referred to as “Aprotinin“, was used during their procedure. The problem is that without looking at the medical records from the day of [...]
Bayer’s widely used Trasylol heart surgery drug was subject to a recall in 2007 following a study that raised safety concerns. Prior to the recall, Trasylol (also referred to as Aprotinin) was used to help prevent excessive bleeding during open heart surgery. The study reported that Bayer’s heart surgery medication increased the risk of dying [...]
Following a Trasylol recall in 2007, Bayer’s heart surgery drug continued to be used during heart surgery even though cheaper and safer alternative drugs were available. Unfortunately, Trasylol was used until as recently as May 2008.In 1993, Trasylol (also referred to as “aprotinin”) received FDA approval for use in certain types of heart surgeries. Until [...]
Bayer’s problems are growing as they face thousands of potential Trasylol lawsuits following increasing reports of their heart surgery drug’s side effects. Trasylol has recently been linked to a higher risk of kidney failure, heart attack, and death in the five years following a patient undergoing bypass heart surgery. In 1993 Trasylol (Aprotinin) was approved [...]